Cargando…
Development, Psychometric Validation and Responder Definition of Worst Itch Scale in Children with Severe Atopic Dermatitis
INTRODUCTION: Itch associated with atopic dermatitis (AD) has a profoundly negative effect on patients of all ages. Therefore, itch is a main target for AD therapeutic approaches, and treatments are perceived as beneficial when they achieve an itch reduction. In the absence of a validated scale for...
Autores principales: | Paller, Amy S., Yosipovitch, Gil, Weidinger, Stephan, DiBenedetti, Dana, Whalley, Diane, Gadkari, Abhijit, Guillemin, Isabelle, Zhang, Haixin, Eckert, Laurent, Chao, Jingdong, Bansal, Ashish, Chuang, Chien-Chia, Delevry, Dimittri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674819/ https://www.ncbi.nlm.nih.gov/pubmed/36269504 http://dx.doi.org/10.1007/s13555-022-00804-z |
Ejemplares similares
-
Peak Pruritus Numerical Rating Scale: psychometric validation and responder definition for assessing itch in moderate‐to‐severe atopic dermatitis
por: Yosipovitch, G., et al.
Publicado: (2019) -
Neuroimmune interactions in chronic itch of atopic dermatitis
por: Yosipovitch, G., et al.
Publicado: (2019) -
Current Clinical Options for the Management of Itch in Atopic Dermatitis
por: Lipman, Zoe M, et al.
Publicado: (2021) -
Definition of Clinically Meaningful Within-Patient Changes in POEM and CDLQI in Children 6 to 11 Years of Age with Severe Atopic Dermatitis
por: Simpson, Eric L., et al.
Publicado: (2021) -
Dupilumab Treatment Provides Sustained Improvements Over 2 Years in Symptoms and Quality of Life in Adults with Atopic Dermatitis
por: Yosipovitch, Gil, et al.
Publicado: (2021)